Technical Analysis for AGL - Angle Plc

Grade Last Price % Change Price Change
F 18.50 1.37% 0.25
AGL closed up 1.37 percent on Friday, June 2, 2023, on 7 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Earnings Movers Other 0.00%
Oversold Stochastic Weakness 0.00%
Hammer Candlestick Bullish 1.37%
Stochastic Buy Signal Bullish 1.37%
Lizard Bullish Bullish Day Trade Setup 1.37%
NR7 Range Contraction 1.37%
NR7-2 Range Contraction 1.37%
Narrow Range Bar Range Contraction 1.37%
Doji - Bullish? Reversal 1.37%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible NR7 3 days ago
Down 1% 3 days ago
Possible Inside Day 4 days ago
Possible NR7 4 days ago
Down 1% 4 days ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Angle Plc Description

ANGLE plc is a holding company. The Company's principal activity is undertaken in relation to the commercialization of its Parsortix cell separation system, with deployment in non-invasive cancer diagnostics. The Company is a specialist medical diagnostic company, which offers products for cancer diagnostics and fetal health. Its Parsortix cell separation system uses a microfluidic technology in the form of a one-time use cassette to capture and then harvest circulating tumor cells (CTCs) from blood. The cassette captures CTCs based on their less deformable nature and larger size compared to other blood components. The resulting liquid biopsy (blood test) enables the detection and investigation of mutations in the patient's cancer for personalized cancer care. The harvested CTCs have a range of applications, including diagnosis, prognosis, mutational analysis and drug selection, drug development, assessment of treatment effectiveness and remission monitoring.


Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Health Medicine Cancer Medical Specialties Monitoring Nature Clinical Medicine Oncology Fluid Offers Products Blood Tumor Drug Development Medical Diagnostic Anatomical Pathology Biopsy Circulating Tumor Cell

Is AGL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 143.0
52 Week Low 15.3
Average Volume 1,904,146
200-Day Moving Average 41.08
50-Day Moving Average 19.94
20-Day Moving Average 19.71
10-Day Moving Average 18.78
Average True Range 1.20
RSI (14) 40.48
ADX 13.59
+DI 17.02
-DI 21.43
Chandelier Exit (Long, 3 ATRs) 19.79
Chandelier Exit (Short, 3 ATRs) 21.59
Upper Bollinger Bands 21.98
Lower Bollinger Band 17.45
Percent B (%b) 0.23
BandWidth 22.98
MACD Line -0.84
MACD Signal Line -0.67
MACD Histogram -0.1685
Fundamentals Value
Market Cap 39.85 Million
Num Shares 215 Million
EPS -6.60
Price-to-Earnings (P/E) Ratio -2.80
Price-to-Sales 76.32
Price-to-Book 3.39
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.25
Resistance 3 (R3) 19.17 18.83 19.13
Resistance 2 (R2) 18.83 18.64 18.88 19.08
Resistance 1 (R1) 18.67 18.52 18.75 18.75 19.04
Pivot Point 18.33 18.33 18.38 18.38 18.33
Support 1 (S1) 18.17 18.14 18.25 18.25 17.96
Support 2 (S2) 17.83 18.02 17.88 17.92
Support 3 (S3) 17.67 17.83 17.88
Support 4 (S4) 17.75